We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBB icon
501
iShares MBS ETF
MBB
$39.1B
$1.23M 0.04%
11,726
+1,520
+15% +$160K
BNY
502
Bank of New York Mellon
BNY
$107B
$1.23M 0.04%
35,047
+2,713
+8% +$88.3K
LEG icon
503
Leggett & Platt
LEG
$1.31B
$1.22M 0.04%
39,489
+4
+0% +$119
SU icon
504
Suncor Energy
SU
$70.3B
$1.21M 0.04%
34,461
+14,846
+76% +$522K
GOGO icon
505
Gogo Inc
GOGO
$492M
$1.2M 0.04%
+48,501
New +$1.12M
VEA icon
506
Vanguard FTSE Developed Markets ETF
VEA
$237B
$1.2M 0.04%
28,785
+22,345
+347% +$906K
WLL
507
DELISTED
Whiting Petroleum Corporation
WLL
$1.2M 0.04%
65
+2
+3% +$37.9K
SBNY
508
DELISTED
Signature Bank
SBNY
$1.2M 0.04%
11,157
-47
-0.4% -$4.81K
PAAS icon
509
Pan American Silver
PAAS
$21.6B
$1.19M 0.04%
101,950
-500
-0.5% -$5.33K
DTV
510
DELISTED
DIRECTV COM STK (DE)
DTV
$1.19M 0.04%
17,224
-1,540
-8% -$98.5K
PGF icon
511
Invesco Financial Preferred ETF
PGF
$672M
$1.19M 0.04%
70,083
-1,735
-2% -$29.7K
PCYC
512
DELISTED
PHARMACYCLICS INC
PCYC
$1.18M 0.04%
11,190
+9,449
+543% +$1.15M
SJNK icon
513
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.8B
$1.18M 0.04%
38,273
+13,117
+52% +$404K
FLG
514
Flagstar Bank National Association
FLG
$5.82B
$1.16M 0.04%
22,972
-6,770
-23% -$328K
IJK icon
515
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$1.16M 0.04%
30,864
+1,168
+4% +$42.1K
EVV
516
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$1.16M 0.04%
75,491
-4,757
-6% -$71.6K
CHKP icon
517
Check Point Software Technologies
CHKP
$13.1B
$1.15M 0.04%
17,774
+555
+3% +$33.4K
ARW icon
518
Arrow Electronics
ARW
$10.4B
$1.14M 0.04%
+21,000
New +$1.07M
SJT
519
San Juan Basin Royalty Trust
SJT
$118M
$1.14M 0.04%
67,800
+838
+1% +$13.8K
TXN icon
520
Texas Instruments
TXN
$261B
$1.13M 0.04%
25,773
+5,469
+27% +$229K
WEN icon
521
Wendy's
WEN
$1.46B
$1.13M 0.04%
129,076
-3,558
-3% -$30.6K
CBRL icon
522
Cracker Barrel
CBRL
$1.29B
$1.13M 0.04%
10,225
-150
-1% -$16.3K
CBST
523
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$1.12M 0.04%
+16,242
New +$1.05M
BWXT icon
524
BWX Technologies
BWXT
$15.6B
$1.12M 0.04%
45,678
+36,954
+424% +$866K
PPC icon
525
Pilgrim's Pride
PPC
$6.54B
$1.11M 0.04%
68,390
+31,220
+84% +$489K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.